GI Cancer Trials

Call Website Contact the organization

GI Cancer Trials GI Cancer Trials (formerly GI Cancer Institute) turns innovative research into hope. Weโ€™re working to change that. Clinical trials are how progress happens.

We fund and conduct clinical trials that accelerate breakthroughs in gastro-intestinal (GI) cancer treatment, improving outcomes for patients and their families. Gastro-Intestinal (GI) cancer is the most common form of cancer in Australia. It affects more than 37,780 Australians each year and claims 50 lives every day. GI cancer includes cancers of the digestive system โ€“ oesophagus, stomach, liver, gallbladder and biliary tract, pancreas, large and small bowel, re**um and a**s. Despite its prevalence, survival rates remain low: the chance of surviving five years after diagnosis is just 48.4%. By uniting a diverse network of brilliant clinicians, researchers, and community advocates, we deliver clinical trials that lead to better treatments, improved quality of life, and longer survival. Since 1991, weโ€™ve conducted 90 research studies, giving more than 9,930 people access to promising new treatments, faster. They test whether new treatments work better than the current standard of care, and theyโ€™re essential to ensuring new therapies are safe, effective, and ready to be used more widely. For patients, clinical trials can offer immediate access to the latest treatments and often improve both outcomes and quality of life. Running trials here in Australia means people can benefit from these advances up to five years earlier than if the trials were held overseas.

Who Magazine Spotlight: Shining a Light on Early-Onset Bowel CancerWe're proud to see our early-onset bowel cancer aware...
14/10/2026

Who Magazine Spotlight: Shining a Light on Early-Onset Bowel Cancer

We're proud to see our early-onset bowel cancer awareness campaign featured in Who Magazine ๐Ÿ’™

GI Cancer Trials Ambassador and medical oncologist Professor Tim Price shared his expert insights, while Ebony Gaylor shared her personal experience with bowel cancer, helping raise awareness of a disease that is increasingly affecting younger Australians.

"The biggest myth is that bowel cancer doesn't occur in young people." - Professor Tim Price

Yet the reality is very different. Rates of bowel cancer among younger Australians are rising, and far too many people remain unaware that it can affect people under 50.

Ebony was just 38, raising her son and working full-time, when a colonoscopy revealed bowel cancer.

"Through this experience, it became clear that the system is not built for a 38-year-old woman balancing parenting and work. There is still so much we don't understand about why younger people are developing GI cancers, and there is so much more we can do to improve treatment and support." - Ebony Gaylor

Knowing the signs and symptoms matters. When bowel cancer is detected early, treatment is often more effective, which is why awareness, screening and early detection are so important.

If something doesn't feel right, don't ignore it. Early detection can save lives.

A big thank you to our PR partner MediaCast for helping bring these important stories to a wider audience.

โ€œYou donโ€™t want to be just surviving. You want to be living.โ€When Jodie was diagnosed with bowel cancer, her first thoug...
13/10/2026

โ€œYou donโ€™t want to be just surviving. You want to be living.โ€

When Jodie was diagnosed with bowel cancer, her first thought wasn't really about herself. It was her daughters.

"As a mum, you're at the centre of so much. Then suddenly, you're faced with the possibility that you might not be."

In her powerful story, Jodie reflects on motherhood, anxiety, sadness, fear and guilt, and what it was like navigating a cancer experience within a system that wasn't equipped for a young family.

That experience also sparked a determination to make things better for the person who comes next.

As Chair of the GI Cancer Trials Community Advisory Panel, Jodie now uses her voice to advocate for patients and families, helping shape research that better reflects their needs and experiences.

Read Jodie's full story -> gicancer.org.au/JodiesStory

๐ŸŒŽ Today on World Mental Health Day, we want to raise awareness and show support for everyone affected by mental health c...
09/10/2026

๐ŸŒŽ Today on World Mental Health Day, we want to raise awareness and show support for everyone affected by mental health challenges, no matter the cause.

It is estimated that 8.5 million Australians aged 16-85 (43%) have experienced a mental health condition at some point in their lives (Source: AIHW).

Mental health challenges affect many people, whether directly through their own experiences or indirectly as family members, friends, carers and loved ones.

Mental health is an important part of the GI cancer experience. Anyone affected by cancer knows that a diagnosis can have a significant effect on mental health and wellbeing, not only for the person diagnosed but also for their family, friends and carers.

This year's theme, Together We Thrive, reminds us that connection, kindness and support can make a real difference to our mental health and wellbeing. By coming together and supporting one another through life's challenges, we can help create a community where everyone feels safe, understood and valued. ๐Ÿฉท๐Ÿฉต๐Ÿ’›๐Ÿ’š

๐ŸŽ‰ We're thrilled to welcome Evonne to the GI Cancer Trials team!As a Clinical Trial Project Manager, Evonne manages the ...
07/10/2026

๐ŸŽ‰ We're thrilled to welcome Evonne to the GI Cancer Trials team!

As a Clinical Trial Project Manager, Evonne manages the operational aspects of clinical trials from start-up to close-out and reporting. She supports the study teamโ€™s day-to-day activities to ensure our trials run smoothly and remain compliant with study protocols and regulatory requirements.

She has a long association with GI Cancer Trials, having previously coordinated several of our studies and served on the Study Coordinators ASM sub-committee.

Evonne loves tackling word puzzles and spending time outdoors with her dog on long neighbourhood walks ๐Ÿถ

"It is a privilege to support our trial participants, their families and friends, and the research teams at our study sites. I love working in clinical trials because they are truly collaborative. Everyone brings their own expertise and experience with the shared hope of improving treatments and outcomes for patients."

Welcome to the team, Evonne โค๏ธ

Do you know the symptoms and risk factors of liver cancer?Early stages of liver cancer are rarely detected as they may n...
06/10/2026

Do you know the symptoms and risk factors of liver cancer?

Early stages of liver cancer are rarely detected as they may not cause symptoms or only show in the form of non-specific symptoms. Most diagnoses occur when liver cancer becomes advanced.

Liver cancer symptoms may include:
- Unexplained loss of weight and appetite
- Unexplained nausea
- Fatigue (weakness and tiredness)
- Pain in the upper right side of the abdomen
- Jaundice (yellowing of the skin and whites of the eyes)
- Pale bowel motions or loose stools
- Severe pain or swelling of the abdomen
- Fever

Early detection is vital, so don't wait - go see your GP if you experience any symptoms.

๐Ÿ“ฃ Learn more about liver cancer, its risk factors and symptoms, visit: gicancer.org.au/LiverCancer

02/10/2026

๐Ÿ“ฃ We are proud to share that the PemOla pancreatic cancer clinical trial has closed for recruitment.

๐Ÿ’ก Why this trial matters?
The PemOla clinical trial, led in Australia by Associate Professor Dan Croagh and Associate Professor Sumitra Ananda (pictured), aims to understand whether patients with high tumour mutational burden (TMB) could respond well to a combination immunotherapy treatment. High TMB can be identified using biological samples from patients with metastatic pancreatic cancer.

โ€œFor patients with metastatic pancreatic cancer, PemOla could represent an important step towards more personalised treatment options. If this combination of immunotherapy and a PARP inhibitor proves effective in patients with high tumour mutational burden, it could provide a new treatment pathway for a group of patients who currently have limited options. The findings could also help drive further research internationally and ultimately improve outcomes for people living with pancreatic cancer.โ€ - Associate Professor Ananda, Study Co-Chair

A huge congratulations to the study team, participating sites and everyone involved in this achievement. Most importantly, thank you to the patients and donors who have made this research possible.

PemOla was generously funded by a Tour de Cure Australia, a Pankind, Pancreatic Cancer Australia Pancreatic Cancer Foundation Limited Research Grant, an Epworth Medical Foundation Grant and GI Cancer Trials philanthropy.

๐Ÿ‘‰ To learn more about the study, visit: gicancer.org.au/PemOla_Closed

October is Liver Cancer Awareness Month. Liver cancer is the sixth highest cause of cancer related deaths in Australia w...
01/10/2026

October is Liver Cancer Awareness Month.

Liver cancer is the sixth highest cause of cancer related deaths in Australia with an estimated 3,175 people diagnosed last year.

Liver cancer is usually diagnosed when it is at an advanced stage and survival outcomes are often influenced by the health and age of the person diagnosed in addition to any pre-existing liver problems, such as cirrhosis, liver disease or infection with hepatitis.

๐ŸŒŸ Trial Spotlight: SOCRATES HCC ๐ŸŒŸ
SOCRATES HCC is testing a precise type of radiation treatment called stereotactic body radiotherapy (SBRT). It is a non-invasive treatment and targets the tumour with high accuracy. Researchers want to find out if SBRT works better than the current standard treatments for people with early-stage liver cancer who cannot have surgery.

The aim of this study is to evaluate the efficacy of SBRT compared to standard of care for the treatment of inoperable, early stage Hepatocellular carcinoma (HCC).

Early detection is vital, so don't wait - go see your GP if you experience any symptoms.

Find out more about liver cancer, here: gicancer.org.au/LiverCancer

TROG Cancer Research - Cancer clinical trials,

A look back at the 2026 Preceptorship in Precision Medicine in GI CancersHeld in Sydney earlier this month, this year's ...
29/09/2026

A look back at the 2026 Preceptorship in Precision Medicine in GI Cancers

Held in Sydney earlier this month, this year's Preceptorship brought together 38 preceptees, 12 expert Preceptors, and participants from across Australia, Aotearoa New Zealand, Japan, the Philippines and the United Kingdom to explore the rapidly evolving field of precision medicine and biomarker-directed therapy in GI cancers.

Across two days, participants reviewed more than 70 papers, engaged in case-based MDT discussions and explored how molecular profiling is increasingly shaping treatment decisions and improving outcomes for patients.

As 2026 preceptee Suellyn Centauri reflected:
โ€œThe combination of expert-led discussions, multidisciplinary perspectives, and international networking made this an incredibly valuable experience. I highly recommend the Preceptorship to anyone with an interest in GI cancer.โ€

A huge thank you to our Convenors, Assistant Co-Convenors, Preceptors, Preceptees, community advocates and sponsors who made this year's programme such a success.

Read the full recap: gicancer.org.au/2026Preceptorship

, Merck ANZ, BeOne Medicines, Pfizer and Pierre Fabre Group.

Meet Nat, our new Operations Coordinator at GI Cancer Trials.Working behind the scenes, Nat helps keep our organisation ...
28/09/2026

Meet Nat, our new Operations Coordinator at GI Cancer Trials.

Working behind the scenes, Nat helps keep our organisation running smoothly by providing support to our CEO and coordinating day-to-day operations, meetings, events and travel logistics across the team.

Before joining GI Cancer Trials, she worked as a Facilities and Office Manager, supporting workplace operations and creating efficient, welcoming environments for staff and visitors.

When she's not at work, you'll find her gardening, hiking, spending time with family, or cooking delicious Latin American and Caribbean food ๐Ÿ’ƒ

We're delighted to have Nat as part of the GI Cancer Trials team โค๏ธ

24/09/2026

- Curious about what a GI cancer clinical trial is and what it might involve?

When diagnosed with a GI cancer, your doctor may suggest the option of participating in a clinical trial. Clinical trials are essential to find better and safer treatments for people with cancer. Trials also provide access to breakthrough medical treatments that can improve the life expectancy and quality of life of the people diagnosed.

Clinical trials are run by teams of researchers at universities, hospitals and private institutions. We've been conducting clinical trials for more than 30 years and there are many doctors and research professionals who volunteer their time to conduct these trials.

If you are interested in participating in a clinical trial, ask your doctor if there is a trial you might be eligible for.

For more info about clinical trials, visit: gicancer.org.au/FAQ

Address

Level 6 119-143 Missenden Road
Camperdown, NSW
2050

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+611300666769

Alerts

Be the first to know and let us send you an email when GI Cancer Trials posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to GI Cancer Trials:

Shortcuts

Share